Worth Asset Management LLC Has $3.25 Million Stake in SPDR S&P Biotech ETF $XBI

Worth Asset Management LLC grew its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 525.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 26,672 shares of the exchange traded fund’s stock after acquiring an additional 22,407 shares during the period. SPDR S&P Biotech ETF accounts for 1.4% of Worth Asset Management LLC’s portfolio, making the stock its 15th largest holding. Worth Asset Management LLC’s holdings in SPDR S&P Biotech ETF were worth $3,252,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of XBI. JPMorgan Chase & Co. boosted its stake in SPDR S&P Biotech ETF by 27.3% in the third quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock worth $1,356,582,000 after purchasing an additional 2,900,633 shares in the last quarter. Bessemer Group Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 9.3% in the third quarter. Bessemer Group Inc. now owns 1,632,988 shares of the exchange traded fund’s stock valued at $163,624,000 after buying an additional 138,322 shares during the last quarter. Ameriprise Financial Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 40.5% in the third quarter. Ameriprise Financial Inc. now owns 1,226,147 shares of the exchange traded fund’s stock valued at $122,906,000 after buying an additional 353,351 shares during the last quarter. Meitav Investment House Ltd. lifted its position in SPDR S&P Biotech ETF by 70.3% during the 3rd quarter. Meitav Investment House Ltd. now owns 682,056 shares of the exchange traded fund’s stock worth $68,156,000 after buying an additional 281,602 shares in the last quarter. Finally, Greenhouse Funds LLLP lifted its position in SPDR S&P Biotech ETF by 16.6% during the 3rd quarter. Greenhouse Funds LLLP now owns 675,975 shares of the exchange traded fund’s stock worth $67,733,000 after buying an additional 96,308 shares in the last quarter.

SPDR S&P Biotech ETF Stock Down 3.5%

Shares of NYSEARCA:XBI opened at $119.59 on Friday. The firm has a market cap of $7.99 billion, a P/E ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 12 month low of $66.66 and a 12 month high of $132.09. The company’s 50-day moving average price is $125.08 and its two-hundred day moving average price is $117.25.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.